Group One Trading
ALXO icon

Group One Trading’s ALX Oncology ALXO Stock Holding History

Group One Trading’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,500
Closed -$6.54K – 7887
2025
Q1 		$6.54K Sell
10,500
-10,300
-50% -$12.4K ﹤0.01% 6518
2024
Q4 		$34.7K Buy
+20,800
New +$32K ﹤0.01% 5326
2024
Q3 		– Sell
-1,400
Closed -$8.44K – 6581
2024
Q2 		$8.44K Sell
1,400
-1,400
-50% -$17.2K ﹤0.01% 5718
2024
Q1 		$31.2K Sell
2,800
-14,500
-84% -$204K ﹤0.01% 5088
2023
Q4 		$258K Buy
+17,300
New +$164K ﹤0.01% 3636

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Group One Trading's ALXO Position: Q1 2026 in Review

Group One Trading sold out of ALX Oncology (ALXO) in Q1 2026, closing a stake of 518 shares — an estimated $987 sold.

Group One Trading first reported a position in ALXO in Q3 2021 and held it in 11 quarters. The position peaked at $27.9K in Q3 2024. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Group One Trading reported no remaining ALX Oncology position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 518 ALX Oncology shares in Q1 2026, an estimated $987.
  • Group One Trading first reported a position in ALX Oncology in Q3 2021 and held it in 11 quarters.
  • Group One Trading's ALX Oncology position peaked at $27.9K in Q3 2024.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.